Christian Dehlendorff

Christian Dehlendorff serves as a Part-time Lecturer in the Department of Pharmacy at the University of Copenhagen. His academic work spans cancer research, pharmacology, and epidemiology, with a focus on drug utilization patterns in cancer patients.

Dr. Dehlendorff's research interests primarily center on cancer pharmacology and epidemiology. His work examines drug utilization patterns before and after cancer diagnoses, with particular attention to hormonal therapies, NSAIDs, and other pharmaceutical interventions across various cancer types including prostate, breast, testicular, and head and neck cancers. His research employs nationwide cohort studies and randomized clinical trials to investigate treatment outcomes, mortality risks, and biomarker responses in cancer patients.

Analysis of his recent publications reveals a strong focus on pharmacoepidemiology in oncology, with particular emphasis on how cancer diagnosis affects medication patterns and how specific drugs impact cancer outcomes. His work frequently utilizes large-scale Danish registry data to conduct population-based studies, demonstrating expertise in both clinical pharmacology and cancer epidemiology.

Dr. Dehlendorff collaborates extensively with researchers across oncology specialties, including urological, gynecological, and head and neck cancers. His work often involves multidisciplinary teams comprising oncologists, epidemiologists, and clinical pharmacologists, reflecting the integrative nature of his research at the intersection of pharmacy and cancer care.